Home › Kanser ng Endometrium › New Mexico
Pag-aaral pangklinika para sa Kanser ng Endometrium sa New Mexico
13 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa New Mexico.
Mga Lungsod sa New Mexico
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of New Mexico Cancer Center, Albuquerque
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- University of New Mexico Cancer Center, Albuquerque
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT05950464Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- University of New Mexico Cancer Center, Albuquerque
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT07198074Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- University of New Mexico Cancer Center, Albuquerque
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601DESTINY-PANTUMOUR04
- Research Site, Farmington
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Albuquerque
Nagre-recruitPhase 2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05489211A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- University of New Mexico Comprehensive Cancer Center ( Site 6046), Albuquerque
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Albuquerque
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Albuquerque
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 292, Albuquerque
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341Uterine Preservation Via Lifestyle Transformation
- University of New Mexico, Albuquerque
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ene 20, 2026 · NCT05903131Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- University of New Mexico, Albuquerque
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Dis 11, 2025 · NCT06795009SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Albuquerque
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.